chevron_leftBack
As of 5 June 2026, iVision Tech S.p.A. has a market cap of $15.76M USD, ranking #38697 globally and #319 in Italy.
It ranks #3449 in the Healthcare sector, and #735 in the Medical Devices industry.
Key Stats
Market Cap
$15.76MUSD
13.57M EUR
Enterprise Value
$25.98MUSD
22.37M EUR
Revenue (TTM)
$23.73MUSD
20.43M EUR
EBITDA (TTM)
$3.27MUSD
2.82M EUR
Net Income (TTM)
$8.49KUSD
7.31K EUR
EBITDA Margin
14%
Profit Margin
0%
PE Ratio
1856.0
Forward PE
90.5
PS Ratio
0.7
PB Ratio
1.3
EV/EBITDA
7.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Stefano Fulchir
open_in_new
Employees
201
Founded
2020
Website
ivisiontech.eu
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2% | -2% | -2.6% | -28% | -21% | -26% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
IVN
Ivision Tech SpA
ISIN: IT0005554784
Shares Out.:
Shares Outstanding:
7.912M1
Shares Float:
2.637M2
|
1.68 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About iVision Tech S.p.A.
iVision Tech S.p.A. designs and produces acetate eyeglass frames and sunglasses, and combination glasses in Italy. The company was incorporated in 2020 and is headquartered in Milan, Italy. iVision Tech S.p.A. operates as a subsidiary of Effe Group S.R.L.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: STVN
|
$4.44B
28K%
|
27.2
|
|
MIL: DIA
|
$3.57B
23K%
3.07B EUR
|
20.3
|
|
MIL: ELN
|
$1.21B
8K%
1.05B EUR
|
21.4
|
|
MIL: SFL
|
$804.96M
5K%
693.03M EUR
|
14.4
|
|
MIL: SVS
|
$55.92M
255%
48.14M EUR
|
7.1
|
|
|
$28.57M
81%
24.6M EUR
|
17.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
1M%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
1M%
|
56.7
|
|
NYSE: ABT
|
$159.07B
1M%
|
25.6
|
|
NYSE: DHR
|
$126.55B
803K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
766K%
|
38.3
|
|
NYSE: MDT
|
$101.9B
646K%
|
22.2
|
chevron_leftBack